Business Wire

CA-AXELSPACE-HOLDINGS

4.3.2024 08:31:30 CET | Business Wire | Press release

Share
Axelspace’s Demonstration Satellite “PYXIS” Scheduled for Launch

Axelspace Corporation’s (Axelspace) demonstration satellite PYXIS is targeted to launch on March 4, 2024 (PST).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240303438505/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Axelspace's demonstration satellite “PYXIS” (Photo: Business Wire)

Axelspace announcement
https://www.axelspace.com/news/pyxislaunch/

The launch is scheduled as follows:

Launch Date: March 4, 2024 (PST)
Launch Vehicle: Falcon 9
Mission of the Launch: Transporter-10
Launch Site: Vandenberg Space Force Base (California, USA)
Orbit: Sun-synchronous orbit, 500 - 600 km altitude
Launch Operator: SpaceX (Space Exploration Technologies Corp.)
*The schedule may change due to other factors such as weather conditions.

PYXIS will work on the following missions in orbit.

  1. Demonstration of the versatile satellite bus system* for AxelLiner
  2. Demonstration of the sensors for the next-generation AxelGlobe satellites (GRUS)
  3. Demonstration of a satellite radio experiment system by SONY Group

PYXIS: https://www.axelspace.com/assets/pdf/history/pyxis_en.pdf

*The bus system is the fundamental satellite operation system, encompassing crucial functions such as attitude control and power supply.

General-purpose (Versatile) satellite bus and In-orbit Demonstration of Deployable Deorbit Mechanism are based on results obtained from the following projects subsidized by the New Energy and Industrial Technology Development Organization (NEDO).

  • Development and Demonstration of General-Purpose CubeSat and Microsatellite Buses (FY2023-2026)
    *This project is implemented by the Ministry of Economy, Trade and Industry from FY2021 to FY2022
  • Program to Support Ventures for Developing Space Components (FY2020-2021)

Company Profile
Axelspace Corporation
Location: Tokyo, Japan
President and CEO: Yuya Nakamura
Main business activities involve the following: Earth observation business using microsatellites; proposals of solutions utilizing microsatellites; designing and manufacturing of microsatellites and related components; launch arrangements for microsatellites; operational support and commissioning.
URL: https://www.axelspace.com/
AxelGlobe: https://www.axelglobe.com/en
AxelLiner: https://www.axelspace.com/solution/

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240303438505/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Mary Kay Extends Winning Streak With Fourth Year as #1 in Global Direct Selling Beauty23.6.2026 14:03:00 CEST | Press release

Euromonitor International Recognizes Mary Kay’s Sustained Leadership In Skin Care And Color Cosmetics Mary Kay Inc., the iconic beauty and entrepreneurship company, has once again been named the #1 Direct Selling Brand of Skin Care and Color Cosmetics in the World1 by Euromonitor International, sustaining its legacy of excellence for the fourth consecutive year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260623487381/en/ Mary Kay Inc., the iconic beauty and entrepreneurship company, for the fourth year in a row has been named the #1 Direct Selling Brand of Skin Care and Color Cosmetics in the World by Euromonitor International. (Image Credit: Mary Kay Inc.) “Earning the #1 global ranking from Euromonitor for the fourth consecutive year comes as a powerful endorsement of the impact of our Independent Beauty Consultants around the world who drive our success every day,” said Ryan Rogers, Chief Executive Officer of Mary Kay

Kobie 2026 Heart of Loyalty Report Reveals Growing Gap Between Consumer Expectations and Brand Loyalty Strategies23.6.2026 14:00:00 CEST | Press release

Global study finds consumers are more ready for AI, more willing to share data, and more motivated by recognition and shared values than many brands realize Kobie, a global leader in loyalty technology and services, today released its 2026 Heart of Loyalty Report, which surveyed both consumers and practitioners, revealing significant gaps between consumer expectations and brand loyalty strategies across AI adoption, data sharing, recognition, advocacy, and community engagement. Kobie's 2026 Heart of Loyalty Report found that: 57% of consumers are willing to engage with AI-powered brand experiences, yet 56% of loyalty practitioners believe customers are not ready for AI. 77% of consumers want recognition from brands, but only 55% feel seen as individuals. 72% of consumers say they would refer a brand without an incentive, yet many referral strategies remain heavily dependent on rewards. Rewards are the strongest driver of willingness to share personal data, yet only 65% of practitioners

Veristat Strengthens Biostatistics, Drug Development Advisory, and People Leadership to Support Growth in Complex Clinical Development23.6.2026 13:05:00 CEST | Press release

Dr. Zhaohui Su and Dr. Gil Fine deepen Veristat’s biostatistics expertise, Scott Tarrant leads Strategic Drug Development Advisory, and Clint Wolfe joins as Chief Human Resources Officer VeristatTM, a global clinical research organization (CRO) and consultancy specializing in complex studies, today announced four strategic leadership hires that advance its mission to accelerate novel therapy approvals in complex disease areas, including cell and gene therapy, oncology, and rare disease. Building on its 30-year foundation in biostatistics and its recent acquisition of the medical writing and regulatory submission business of Certara, Veristat is deepening its scientific expertise and expanding its operational leadership to meet growing client demand. Dr. Zhaohui Su and Dr. Gil Fine join Veristat’s Strategic Drug Development Advisory team in biostatistical leadership roles, collaborating with Scott Tarrant, who has been named Executive Vice President of the team. In addition, Clint Wolfe

Bacardi Takes Full Ownership of TEELING® Irish Whiskey23.6.2026 13:00:00 CEST | Press release

Irish whiskey brand joins family-owned company’s portfolio of premium brands Bacardi Limited has announced the completion of a transaction that makes the family-owned company the sole owner of the Teeling Whiskey Company and the TEELING® Irish whiskey brand. Founders Jack and Stephen Teeling will remain a part of the brand, shaping its future and driving growth for the long term as strategic advisors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260623858211/en/ Three expressions of Teeling Irish Whiskey: Single Grain, Small Batch and Single Malt Today’s announcement follows the successful relationship the two companies have enjoyed since Bacardi acquired a minority stake in the Dublin-based whiskey company in 2017. Bacardi subsequently increased its stake to become the majority shareholder in 2022. “TEELING is the perfect fit for Bacardi,” says Mahesh Madhavan, Chief Executive Officer, Bacardi Limited. “The brand stands f

Bending Spoons S.p.A. announces launch of initial public offering23.6.2026 12:15:00 CEST | Press release

Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the launch of its initial public offering (the “IPO”) of its ordinary shares. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 are being offered by Bending Spoons and 23,572,375 are being offered by certain selling shareholders (the “Selling Shareholders”). In connection with the offering, Bending Spoons and the Selling Shareholders have granted the underwriters a 30-day option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and an additional 3,451,626 ordinary shares from the Selling Shareholders at the IPO price, less underwriting discounts and commissions. The IPO price is currently estimated to be between $26.00 and $28.00 per share. Bending Spoons has applied to list its ordinary shares on the Nasdaq Global Select Market under the ticker symbol “BSP.” Goldman Sachs International, J.P. Morgan, and Allen & Company LLC are acting as joint l

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye